A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa
Clinical trial NCT06891885 · RECRUITING
Trial details
- NCT number
- NCT06891885
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-16
- Primary completion
- 2028-10-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.